Holding(s) in Company

RNS Number : 7732H
Dechra Pharmaceuticals PLC
26 February 2010
 



 




 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Dechra Pharmaceuticals PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):


3. Full name of person(s) subject to the
notification obligation:
iii

BlackRock, Inc.

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

23rd February 2010

6. Date on which issuer notified:

26th February 2010

7. Threshold(s) that is/are crossed or
reached:
vi, vii

Holding has gone below 5%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0009633180

3,393,582

3,393,582

N/A

N/A

3,086,592

N/A

4.68%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 






Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,086,592

4.68%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

BlackRock Investment Management (UK) Limited - 3,086,592 (4.68%)

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:

BlackRock Compliance Disclosures Team

14. Contact name:

Stuart Watchorn

15. Contact telephone number:

020 7743 5741; stuart.watchorn@blackrock.com



 

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification of major interests in share


A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

BlackRock, Inc.

Contact address

(registered office for legal entities)

 

33 King William Street, London, EC4R 9AS

Phone number & email

 

020 7743 5741; stuart.watchorn@blackrock.com

Other useful information

(at least legal representative for legal persons)

 

Stuart Watchorn



B: Identity of the notifier, if applicable

Full name

 


Contact address

 


Phone number & email

 


Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)



C: Additional information


For notes on how to complete form TR-1 please see the FSA website.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDMGZZDVGGGZM
UK 100

Latest directors dealings